Literature DB >> 7862171

The ligand-binding domains of the thyroid hormone/retinoid receptor gene subfamily function in vivo to mediate heterodimerization, gene silencing, and transactivation.

J S Qi1, V Desai-Yajnik, M E Greene, B M Raaka, H H Samuels.   

Abstract

The ligand-binding domains (LBDs) of the thyroid/retinoid receptor gene subfamily contain a series of heptad motifs important for dimeric interactions. This subfamily includes thyroid hormone receptors (T3Rs), all-trans retinoic acid (RA) receptors (RARs), 9-cis RA receptors (RARs and retinoid X receptors [RXRs]), the 1,25-dihydroxyvitamin D3 receptor (VDR), and the receptors that modulate the peroxisomal beta-oxidation pathway (PPARs). These receptors bind to their DNA response elements in vitro as heterodimers with the RXRs. Unliganded receptors in vivo, in particular the T3Rs, can mediate gene silencing and ligand converts these receptors into a transcriptionally active form. The in vivo interactions of these receptors with RXR were studied by using a GAL4-RXR chimera containing the yeast GAL4 DNA-binding domain and the LBD of RXR beta. GAL4-RXR activates transcription from GAL4 response elements in the presence of 9-cis RA. Unliganded T3R, which does not bind or activate GAL4 elements, represses the activation of GAL4-RXR by 9-cis RA in HeLa cells. However, addition of T3 alone leads to transcriptional activation. These findings suggest that T3R can repress or activate transcription while tethered to the LBD of GAL4-RXR and that heterodimerization can occur in vivo without stabilization by hormone response elements. Similar ligand-dependent activation was observed in HeLa cells expressing RAR, VDR, or PPAR and in GH4C1 cells from endogenous receptors. Replacement of the last 17 amino acids of the LBD of RXRbeta with the 90-amino-acid transactivating domain of the herpes simplex virus VP16 protein leads to a GAL4 constitutive activator that is repressed by wild-type T3R but not by a ninth heptad mutant that does not form heterodimers. This finding suggests that the ninth heptad or T3R is important for gene silencing and that the LBD of RXR does not exhibit silencing activity. This conclusion was verified with GAL4-LBD chimeras and with wild-type receptors in assays using appropriate response elements. These studies indicate that the LBD has diverse functional roles in gene regulation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7862171      PMCID: PMC230406          DOI: 10.1128/MCB.15.3.1817

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  66 in total

1.  Half-site spacing and orientation determines whether thyroid hormone and retinoic acid receptors and related factors bind to DNA response elements as monomers, homodimers, or heterodimers.

Authors:  B M Forman; J Casanova; B M Raaka; J Ghysdael; H H Samuels
Journal:  Mol Endocrinol       Date:  1992-03

2.  Functional dissection of VP16, the trans-activator of herpes simplex virus immediate early gene expression.

Authors:  S J Triezenberg; R C Kingsbury; S L McKnight
Journal:  Genes Dev       Date:  1988-06       Impact factor: 11.361

3.  Discrete cis-active genomic sequences dictate the pituitary cell type-specific expression of rat prolactin and growth hormone genes.

Authors:  C Nelson; E B Crenshaw; R Franco; S A Lira; V R Albert; R M Evans; M G Rosenfeld
Journal:  Nature       Date:  1986 Aug 7-13       Impact factor: 49.962

4.  Cloning and expression of full-length cDNA encoding human vitamin D receptor.

Authors:  A R Baker; D P McDonnell; M Hughes; T M Crisp; D J Mangelsdorf; M R Haussler; J W Pike; J Shine; B W O'Malley
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

5.  Regulation of pituitary function and prolactin production in the GH4 cell line by vitamin D.

Authors:  G H Murdoch; M G Rosenfeld
Journal:  J Biol Chem       Date:  1981-04-25       Impact factor: 5.157

6.  cis-acting elements of the rat growth hormone gene which mediate basal and regulated expression by thyroid hormone.

Authors:  F Flug; R P Copp; J Casanova; Z D Horowitz; L Janocko; M Plotnick; H H Samuels
Journal:  J Biol Chem       Date:  1987-05-05       Impact factor: 5.157

7.  A transferable silencing domain is present in the thyroid hormone receptor, in the v-erbA oncogene product and in the retinoic acid receptor.

Authors:  A Baniahmad; A C Köhne; R Renkawitz
Journal:  EMBO J       Date:  1992-03       Impact factor: 11.598

Review 8.  The steroid and thyroid hormone receptor superfamily.

Authors:  R M Evans
Journal:  Science       Date:  1988-05-13       Impact factor: 47.728

9.  RXR alpha, a promiscuous partner of retinoic acid and thyroid hormone receptors.

Authors:  T H Bugge; J Pohl; O Lonnoy; H G Stunnenberg
Journal:  EMBO J       Date:  1992-04       Impact factor: 11.598

10.  H-2RIIBP (RXR beta) heterodimerization provides a mechanism for combinatorial diversity in the regulation of retinoic acid and thyroid hormone responsive genes.

Authors:  M S Marks; P L Hallenbeck; T Nagata; J H Segars; E Appella; V M Nikodem; K Ozato
Journal:  EMBO J       Date:  1992-04       Impact factor: 11.598

View more
  25 in total

1.  Rational discovery of novel nuclear hormone receptor antagonists.

Authors:  M Schapira; B M Raaka; H H Samuels; R Abagyan
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

2.  Domain structure of the NRIF3 family of coregulators suggests potential dual roles in transcriptional regulation.

Authors:  D Li; F Wang; H H Samuels
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

3.  A novel role for helix 12 of retinoid X receptor in regulating repression.

Authors:  J Zhang; X Hu; M A Lazar
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

4.  Regulation of the mdm2 oncogene by thyroid hormone receptor.

Authors:  J S Qi; Y Yuan; V Desai-Yajnik; H H Samuels
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

5.  Activation and repression by nuclear hormone receptors: hormone modulates an equilibrium between active and repressive states.

Authors:  I G Schulman; H Juguilon; R M Evans
Journal:  Mol Cell Biol       Date:  1996-07       Impact factor: 4.272

6.  Molecular mechanisms of COUP-TF-mediated transcriptional repression: evidence for transrepression and active repression.

Authors:  X Leng; A J Cooney; S Y Tsai; M J Tsai
Journal:  Mol Cell Biol       Date:  1996-05       Impact factor: 4.272

7.  Therapeutic Implications of PPARgamma in Human Osteosarcoma.

Authors:  Eric R Wagner; Bai-Cheng He; Liang Chen; Guo-Wei Zuo; Wenli Zhang; Qiong Shi; Qing Luo; Xiaoji Luo; Bo Liu; Jinyong Luo; Farbod Rastegar; Connie J He; Yawen Hu; Barrett Boody; Hue H Luu; Tong-Chuan He; Zhong-Liang Deng; Rex C Haydon
Journal:  PPAR Res       Date:  2010-02-16       Impact factor: 4.964

8.  Novel receptor interaction and repression domains in the orphan receptor SHP.

Authors:  W Seol; M Chung; D D Moore
Journal:  Mol Cell Biol       Date:  1997-12       Impact factor: 4.272

9.  Constitutive activation of gene expression by thyroid hormone receptor results from reversal of p53-mediated repression.

Authors:  J S Qi; V Desai-Yajnik; Y Yuan; H H Samuels
Journal:  Mol Cell Biol       Date:  1997-12       Impact factor: 4.272

10.  Functional evidence for retinoid X receptor (RXR) as a nonsilent partner in the thyroid hormone receptor/RXR heterodimer.

Authors:  Dangsheng Li; Tong Li; Fang Wang; Heather Tian; Herbert H Samuels
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.